Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200046/S048

Harmony TPV System

Medtronic, Inc. · Decision date Mar 6, 2026

FDA DECISIONP200046/S048

What did the FDA approve?

FDA records P200046/S048 as a supplement to PMA P200046, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Mar 6, 2026.

FDA approval order statement

Approval of the revised protocols for PAS1, "Continued Follow-up of the Harmony TPV IDE Cohort," and PAS2, "Harmony TPV New Enrollment Study." The PAS protocols have been submitted to comply with the conditions of approval outlined in the approval order for P200046.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Mar 6, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P200046/S048
Regulatory pathway
PMA supplement
Product code
NPV
Decision code
APPR
Decision date
Mar 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulmonary valve prosthesis percutaneously delivered.

Product code
NPV
FDA device class
f

For the original device and its historical approval scope, see PMA P200046. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200046 · Original PMA

    Harmony TPV System

  2. P200046/S044 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  3. P200046/S047 · Related supplement

    Harmony Transcatheter Pulmonic Valve System

  4. P200046/S048 received

    Application receipt date recorded by FDA.

  5. P200046/S049 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  6. P200046/S046 · Related supplement

    Harmony Delivery Catheter System (HARMONY-DCS)

  7. P200046/S045 · Related supplement

    Harmony Transcatheter Pulmonary Valve

  8. P200046/S048 · FDA decision

    Normal 180 Day Track No User Fee

  9. P200046/S050 · Related supplement

    Harmony Transcatheter Pulmonary Valve System

  10. P200046/S051 · Related supplement

    Harmony Transcatheter Pulmonary Valve

Timeline entries are records held by MedtechLedger for P200046. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200046

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA approvalMar 26, 2021FDA
Harmony TPV SystemP200046/S043
Medtronic, Inc.PMA supplementSep 5, 2025FDA
Medtronic, Inc.PMA supplementOct 23, 2025FDA
Medtronic, Inc.PMA supplementJan 16, 2026FDA
Medtronic, Inc.PMA supplementFeb 10, 2026FDA
Medtronic, Inc.PMA supplementFeb 11, 2026FDA
Medtronic, Inc.PMA supplementFeb 12, 2026FDA
Medtronic, Inc.PMA supplementMar 24, 2026FDA
Medtronic, Inc.PMA supplementJun 1, 2026FDA
Harmony TPV SystemP200046/S052
Medtronic, Inc.PMA supplementSep 30, 2026FDA

Explore the linked device profile

Other records with product code NPV

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3576 Unocal Pl., Bldg. A, Santa Rosa, CA, 95403

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records